ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,673 | 40,589 | 38,233 | 43,008 | 44,136 |
| Receivables | 70,700 | 76,274 | 67,410 | 64,842 | 67,647 |
| Inventories | 46,174 | 45,296 | 42,032 | 40,503 | 40,006 |
| TOTAL | $182,386 | $168,912 | $151,832 | $152,877 | $156,793 |
| Non-Current Assets | |||||
| PPE Net | 39,754 | 38,953 | 38,425 | 38,090 | 37,418 |
| Intangibles | 191,952 | 200,277 | 208,680 | 205,184 | 213,724 |
| Other Non-Current Assets | 42,683 | 38,764 | 35,453 | 34,453 | 31,508 |
| TOTAL | $274,389 | $277,994 | $282,558 | $277,727 | $282,650 |
| Total Assets | $456,775 | $446,906 | $434,390 | $430,604 | $439,443 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,154 | 4,149 | 3,243 | 3,256 | 5,692 |
| Accounts payable and accrued liabilities | 10,953 | 9,809 | 10,519 | 8,884 | 7,257 |
| Accrued Expenses | 37,518 | 36,420 | 33,079 | 35,213 | 32,900 |
| TOTAL | $170,707 | $166,794 | $165,068 | $165,549 | $46,902 |
| Non-Current Liabilities | |||||
| Long Term Debt | 64,873 | 65,688 | 66,501 | 67,296 | 65,954 |
| Deferred Revenues | 496 | 558 | 624 | 711 | 735 |
| Other Non-Current Liabilities | 8,065 | 6,768 | 3,109 | 496 | 134,122 |
| TOTAL | $72,938 | $72,456 | $69,610 | $67,792 | $200,076 |
| Total Liabilities | $243,645 | $239,250 | $234,678 | $233,341 | $246,978 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,091 | 12,097 | 12,048 | 11,862 | 11,858 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | 22,419 | 18,524 | 11,939 | 11,488 | 6,058 |
| Other shareholders' equity | -5,760 | -4,736 | -2,199 | -38 | 874 |
| TOTAL | $213,130 | $207,656 | $199,712 | $197,263 | $192,465 |
| Total Liabilities And Equity | $456,775 | $446,906 | $434,390 | $430,604 | $439,443 |